HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION OF PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER
https://doi.org/10.17650/1726-9776-2014-10-2-58-61
Abstract
In this study the results of retrospective analysis of treatment of 311 patients in Samara Oncology Center in 2008–2011 with locally advanced prostate cancer are presented. According to the received treatment patients were divided into 3 groups: 103 underwent HIFU, 101 patients had a course of EBRT, 107 patients received only hormone therapy (HT). Overall survival in patients with locally advanced prostate cancer after HIFU therapy was 86.2 %, after EBRT and HT – 66.3% and 18.1 %, respectively. These data indicate a high clinical efficacy of ultrasound ablation.
About the Authors
L. V. Shaplygin
Regional Clinical Oncology Dispensary, Samara
Russian Federation
Russian Federation
V. A. Solovov
Regional Clinical Oncology Dispensary, Samara
Russian Federation
Russian Federation
M. O. Vozdvizhenskiy
Regional Clinical Oncology Dispensary, Samara
Russian Federation
Russian Federation
Yа. S. Matyash
Regional Clinical Oncology Dispensary, Samara
Russian Federation
Russian Federation
R. Z. Khametov
Regional Clinical Oncology Dispensary, Samara
Russian Federation
Russian Federation
D. V. Fesenko
Regional Clinical Oncology Dispensary, Samara
Russian Federation
Russian Federation
References
1. American Cancer Society. Facts and Figures. Atlanta, Ga, USA: American Cancer Society. 2012.
2. Состояние онкологической помощи на-селению России в 2012 г. Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2013. С. 11–16.
3. Guidelines on Prostate Cancer. A. Heidenreich (chair), P.J. Bastian, J. Bellmunt et al. EAU. 2013.
4. Abdollah F., Sun M., Schmitges J. et al. Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics. J Urol 2012;188:73–83.
5. Warde P., Mason M., Ding K. et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet 2011;378:2104–11.
Review
For citations:
Shaplygin L.V., Solovov V.A., Vozdvizhenskiy M.O., Matyash Y.S., Khametov R.Z., Fesenko D.V. HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION OF PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER. Cancer Urology. 2014;10(2):58-61. (In Russ.) https://doi.org/10.17650/1726-9776-2014-10-2-58-61
Views:
723
Email this article 